Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2004-02-18
2008-11-25
Shiao, Rei-tsang (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C558S166000, C558S169000
Reexamination Certificate
active
07456157
ABSTRACT:
Aminophosphonic acid derivatives (e.g., 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonate monoester) are represented by the following general formula (1):and act as effective S1P receptor modulators while posing less side effects.
REFERENCES:
patent: 5447922 (1995-09-01), Lawrence et al.
patent: 7179817 (2007-02-01), Seko et al.
patent: 7288558 (2007-10-01), Nakade et al.
patent: 2004/0067908 (2004-04-01), Nakade et al.
patent: 2004/0224941 (2004-11-01), Seko et al.
patent: 2004/0235794 (2004-11-01), Nakade et al.
patent: 2007/0088027 (2007-04-01), Seko et al.
patent: 2003-137894 (2003-05-01), None
patent: 01/98301 (2001-12-01), None
patent: 02/18395 (2002-03-01), None
patent: 02/062389 (2002-08-01), None
patent: 02/064616 (2002-08-01), None
patent: 02/076995 (2002-10-01), None
patent: 02/092068 (2002-11-01), None
patent: 03/020313 (2003-03-01), None
patent: 03/040097 (2003-05-01), None
patent: 03/051876 (2003-06-01), None
patent: 03/061567 (2003-07-01), None
patent: 03/062248 (2003-07-01), None
patent: 03/062252 (2003-07-01), None
patent: 03/073986 (2003-09-01), None
patent: 2004/024673 (2004-03-01), None
patent: WO2004074297 (2004-09-01), None
Y. Igarashi, “Sphingosine-1-phosphate as an intercellular signaling molecule”, Ann. N.Y. Acad. Sci., 845, 19, 1998, abstract only.
Yoh Takuwa et al., “Subtype-specific, differential activities of the EDG family receptors for sphingosine-1-phosphate, a novel lysophospholipid mediator”, Molecular and Cellular Endocrinology, vol. 177, pp. 3-11, 2001.
Hiroshi Okazaki et al., “Molecular Cloning of a Novel Putative G Protein-Coupled Receptor Expressed in the Cardiovascular System”, Biochemical and Biophysical Research Communications, vol. 190, No. 3, pp. 1104-1109, Feb. 15, 1993.
Suzanne Mandala et al., “Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists”, Science, vol. 296, pp. 346-349, Apr. 12, 2002.
Volker Brinkmann et al., “The Immune Modulator FTY720 Targets Sphingosine-1-Phosphate Receptors”, The Journal of Biological Chemistry, vol. 277, No. 24, pp. 21453-21457, Jun. 14, 2002.
Hori Wataru
Kohno Yasushi
Kuriyama Kazuhiko
Tanaka Kiyoaki
Kyorin Pharmaceutical Co. Ltd.
Shiao Rei-tsang
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Aminophosphonic acid derivatives, addition salts thereof and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminophosphonic acid derivatives, addition salts thereof and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminophosphonic acid derivatives, addition salts thereof and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4022553